SCRYB Insider Trading

CSE NP


2

All Trades

1

Significant

1

Notable

2

Clusters

0

Repeat

Financial Services

Sector

Asset Management

Industry

$5.6M

Market Cap

0.09 – 0.15

52 Week Range

146K

Avg. Volume


CompanyInsiderTitleDateSharesPriceValueBalanceIncreaseSignal
SCRYBVan Staveren, GregoryCEO29-Jan-26521,000$0.11$56,268601,000651%SI CL
SCRYBVan Staveren, JamesCEO29-Jan-26250,000$0.11$27,5001,354,50023%NT CL

SCRYB (NP): Insider trading  △ Insider buy

$█.██
$█.██
$█.██
$█.██
$█.██

Volume (thousands)

Company Info

Company Description: SCRYB

SCRYB is a company listed on the Canadian Securities Exchange under the ticker CSE:SCYB. Based on the company name and typical sector positioning, SCRYB operates in the biotechnology or life sciences space, likely focusing on innovative research, diagnostics, or therapeutic development. The company is incorporated in Canada and maintains operations within the Canadian market while potentially serving international clients and partners.

As a publicly traded entity on the CSE, SCRYB is subject to Canadian securities regulations and reporting requirements. The company operates within the competitive landscape of Canadian biotech and life sciences firms, positioning itself to attract institutional and retail investors interested in emerging healthcare technologies. Like other CSE-listed companies, SCRYB’s operational focus and commercial activities are disclosed through regular filings with Canadian securities authorities. Investors seeking detailed information about the company’s specific products, revenue streams, partnerships, and financial performance are advised to consult official regulatory filings, investor relations materials, and current company announcements available through CSE databases and the company’s official channels.






Don’t miss today’s trades

Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.

Subscribe Now